Project Description

Commercial Manufacturing Facility
El Segundo, CA

The new 44, 500 sf state-of-the-art commercial cGMP manufacturing facility enables the development of novel cancer immunotherapy products to be used for clinical trials in the treatment of patients with blood cancer.  Adjacent to Los Angeles International Airport, the facility is strategically located so that it can accommodate up to 5,000 patient therapies per year from across the country.  Equipped with numerous resources, the space houses manufacturing, quality, facilities, IT, and research and development office space.